Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amarin Corporation PLC (NASDAQ:AMRN)

2.35
Delayed Data
As of Sep 04
 +0.06 / +2.62%
Today’s Change
0.78
Today|||52-Week Range
3.33
+139.87%
Year-to-Date

Today’s Trading

Previous close2.29
Today’s open2.23
Day’s range2.23 - 2.39
Volume1,138,491
Average volume (3 months)1,711,754
Market cap$418.0M
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)+68.97%
Earnings growth (this year)-102.08%
Earnings growth (next 5 years)+134.00%
Revenue growth (last year)+105.45%
P/E ratioNM
Price/Sales3.15
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo BioSciences ...-0.06-0.90%
ARWRArrowhead Research C...+0.04+0.73%
BSTCBiospecifics Technol...+1.64+3.49%
ONTYOncothyreon Inc-0.10-2.99%
Data as of 3:59pm ET, 09/04/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$54.0M
Annual profit (last year)-$56.1M
Net profit margin-103.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John F. Thero
Chief Financial &
Accounting Officer
Michael J. Farrell
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers